KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $92.0 million.

  • Elanco Animal Health's Capital Expenditures rose 11904.76% to $92.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $261.0 million, marking a year-over-year increase of 8510.64%. This contributed to the annual value of $147.0 million for FY2024, which is 500.0% up from last year.
  • According to the latest figures from Q3 2025, Elanco Animal Health's Capital Expenditures is $92.0 million, which was up 11904.76% from $57.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Capital Expenditures registered a high of $99.0 million during Q4 2021, and its lowest value of $17.0 million during Q2 2021.
  • Over the past 5 years, Elanco Animal Health's median Capital Expenditures value was $39.0 million (recorded in 2022), while the average stood at $43.7 million.
  • Data for Elanco Animal Health's Capital Expenditures shows a peak YoY increase of 25357.14% (in 2021) and a maximum YoY decrease of 7159.09% (in 2021) over the last 5 years.
  • Elanco Animal Health's Capital Expenditures (Quarter) stood at $99.0 million in 2021, then fell by 22.22% to $77.0 million in 2022, then tumbled by 46.75% to $41.0 million in 2023, then increased by 14.63% to $47.0 million in 2024, then surged by 95.74% to $92.0 million in 2025.
  • Its Capital Expenditures was $92.0 million in Q3 2025, compared to $57.0 million in Q2 2025 and $65.0 million in Q1 2025.